Editorial Kenneth Frazier, a former chief executive of drug giant Merck who is on the board of Paradigm, in Palo Alto, Calif. on Jan. 11, 2023. (Jason Henry/The New York Times)
Editorial Kenneth Frazier, a former chief executive of drug giant Merck who is on the board of Paradigm, in Palo Alto, Calif. on Jan. 11, 2023. (Jason Henry/The New York Times)